C2A Security Acquires Vigilant Ops to Expand AI-Powered Product Security

Oct 20, 2025
C2A Security has acquired Pittsburgh-based Vigilant Ops, a company specializing in product security and SBOM automation for healthcare and MedTech organizations. The acquisition enhances C2A's AI-driven security platform and broadens its reach into regulated industries.

C2A Security has acquired Pittsburgh-based Vigilant Ops, announced in a press release. Vigilant Ops is known for its expertise in product security and Software Bill of Materials (SBOM) automation for healthcare and MedTech sectors.

The acquisition integrates Vigilant Ops’ compliance and transparency capabilities into C2A Security’s AI-driven product security orchestration platform. This combination enhances risk management and AI-SOAR (Security, Orchestration, Automation, and Response) features for organizations developing connected healthcare technologies.

Founded in 2019, Vigilant Ops supports clients including Bayer and Ascensia, focusing on FDA and EU MDR compliance. With the merger, C2A Security expands its global presence and strengthens its position in industries requiring rigorous supply-chain and regulatory security.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.